S&P 500   4,467.71
DOW   35,123.36
QQQ   367.91
2 Tech Stocks to Buy and One to Avoid in August
His system isolated NVIDIA - Here's His Next Buy. (Ad)
3 Stocks to Buy No Matter Which Way Inflation Moves
3 Stocks to Buy After Heavy Insider Buying
Bizarre Amazon Secret — Not Available on CNN, Fox, or MSNBC (Ad)
2 Alternatives To Tesla (1 Safe, 1 More Risky)
The Rivian Market Is About To Shift Into A Higher Gear 
The single greatest medical breakthrough of all time? (Ad)
7 Best Fintech ETFs to Buy Now
How major US stock indexes fared Wednesday, 8/9/2023
S&P 500   4,467.71
DOW   35,123.36
QQQ   367.91
2 Tech Stocks to Buy and One to Avoid in August
His system isolated NVIDIA - Here's His Next Buy. (Ad)
3 Stocks to Buy No Matter Which Way Inflation Moves
3 Stocks to Buy After Heavy Insider Buying
Bizarre Amazon Secret — Not Available on CNN, Fox, or MSNBC (Ad)
2 Alternatives To Tesla (1 Safe, 1 More Risky)
The Rivian Market Is About To Shift Into A Higher Gear 
The single greatest medical breakthrough of all time? (Ad)
7 Best Fintech ETFs to Buy Now
How major US stock indexes fared Wednesday, 8/9/2023
S&P 500   4,467.71
DOW   35,123.36
QQQ   367.91
2 Tech Stocks to Buy and One to Avoid in August
His system isolated NVIDIA - Here's His Next Buy. (Ad)
3 Stocks to Buy No Matter Which Way Inflation Moves
3 Stocks to Buy After Heavy Insider Buying
Bizarre Amazon Secret — Not Available on CNN, Fox, or MSNBC (Ad)
2 Alternatives To Tesla (1 Safe, 1 More Risky)
The Rivian Market Is About To Shift Into A Higher Gear 
The single greatest medical breakthrough of all time? (Ad)
7 Best Fintech ETFs to Buy Now
How major US stock indexes fared Wednesday, 8/9/2023
S&P 500   4,467.71
DOW   35,123.36
QQQ   367.91
2 Tech Stocks to Buy and One to Avoid in August
His system isolated NVIDIA - Here's His Next Buy. (Ad)
3 Stocks to Buy No Matter Which Way Inflation Moves
3 Stocks to Buy After Heavy Insider Buying
Bizarre Amazon Secret — Not Available on CNN, Fox, or MSNBC (Ad)
2 Alternatives To Tesla (1 Safe, 1 More Risky)
The Rivian Market Is About To Shift Into A Higher Gear 
The single greatest medical breakthrough of all time? (Ad)
7 Best Fintech ETFs to Buy Now
How major US stock indexes fared Wednesday, 8/9/2023
NASDAQ:CLPT

ClearPoint Neuro (CLPT) Price Target & Analyst Ratings

$6.22
-0.18 (-2.81%)
(As of 08/9/2023 ET)
Compare
Today's Range
$5.92
$6.51
50-Day Range
$6.40
$7.77
52-Week Range
$5.92
$16.96
Volume
316,277 shs
Average Volume
118,125 shs
Market Capitalization
$152.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.00

ClearPoint Neuro Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Buy
Based on 1 Analyst Ratings

Consensus Analyst Price Target

$14.50
133.12% Upside
High Prediction$15.00
Average Prediction$14.50
Low Prediction$14.00
TypeCurrent
8/10/22 to 8/10/23
1 Month Ago
7/11/22 to 7/11/23
3 Months Ago
5/12/22 to 5/12/23
1 Year Ago
8/10/21 to 8/10/22
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$14.50$14.00$14.00$15.00
Predicted Upside133.12% Upside53.85% Upside53.85% Upside32.98% Upside
Get ClearPoint Neuro Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CLPT and its competitors with MarketBeat's FREE daily newsletter.


CLPT Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CLPT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

ClearPoint Neuro Stock vs. The Competition

TypeClearPoint NeuroMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.65
2.48
Consensus RatingBuyModerate BuyHold
Predicted Upside133.12% Upside5,105.36% Upside636.80% Upside
News Sentiment RatingNegative News
Neutral News
Neutral News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/9/2023Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$22.00 ➝ $15.00+148.76%
2/16/2023B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
N. Chatterji
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$14.00+53.85%
(Data available from 8/10/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












CLPT Price Target - Frequently Asked Questions

What is ClearPoint Neuro's consensus rating and price target?

According to the issued ratings of 1 analysts in the last year, the consensus rating for ClearPoint Neuro stock is Buy based on the current 1 buy rating for CLPT. The average twelve-month price prediction for ClearPoint Neuro is $14.50 with a high price target of $15.00 and a low price target of $14.00. Learn more on CLPT's analyst rating history.

Do Wall Street analysts like ClearPoint Neuro more than its competitors?

Analysts like ClearPoint Neuro more than other Medical companies. The consensus rating for ClearPoint Neuro is Buy while the average consensus rating for medical companies is Moderate Buy. Learn more on how CLPT compares to other companies.

Does ClearPoint Neuro's stock price have much upside?

According to analysts, ClearPoint Neuro's stock has a predicted upside of 79.53% based on their 12-month price targets.

What analysts cover ClearPoint Neuro?

ClearPoint Neuro has been rated by Lake Street Capital in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:CLPT) was last updated on 8/10/2023 by MarketBeat.com Staff

My Account -